Mainz Biomed N.V (NASDAQ: MYNZ) Is Expected To Soar To Higher Prices In The Months To Come.

In the latest trading session,, 1.73 million Mainz Biomed N.V (NASDAQ:MYNZ) shares changed hands as the company’s beta touched 0.49. With the company’s most recent per share price at $4.12 changing hands around $0.59 or 16.71% at last look, the market valuation stands at $12.52M. MYNZ’s current price is a discount, trading about -880.58% off its 52-week high of $40.40. The share price had its 52-week low at $2.65, which suggests the last value was 35.68% up since then. When we look at Mainz Biomed N.V’s average trading volume, we note the 10-day average is 94150.0 shares, with the 3-month average coming to 216.75K.

Mainz Biomed N.V (NASDAQ:MYNZ) trade information

Instantly MYNZ is in green as seen in intraday trades today. With action 34.20%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.63%, with the 5-day performance at 34.20% in the green. However, in the 30-day time frame, Mainz Biomed N.V (NASDAQ:MYNZ) is 3.83% up. Looking at the short shares, we see there were 69425.0 shares sold at short interest cover period of 0.53 days.

Mainz Biomed N.V (MYNZ) estimates and forecasts

Year-over-year growth is forecast to reach 40.10% up from the last financial year.

Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 300k. 1 analysts are of the opinion that Mainz Biomed N.V’s revenue for the current quarter will be 400k.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -52.02%. The 2025 estimates are for Mainz Biomed N.V earnings to increase by 64.02%, but the outlook for the next 5-year period is at 43.17% per year.

MYNZ Dividends

Mainz Biomed N.V is expected to release its next quarterly earnings report on 2025-Mar-30.

Mainz Biomed N.V (NASDAQ:MYNZ)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 3.21% of Mainz Biomed N.V shares while 1.02% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.05%. There are 1.02% institutions holding the Mainz Biomed N.V stock share, with NORTHERN TRUST CORP the top institutional holder. As of 2024-06-30, the company held 0.1414% of the shares, roughly 29934.0 MYNZ shares worth $12004.0.

VONTOBEL HOLDING LTD. holds the second largest percentage of outstanding shares, with 0.1181% or 25000.0 shares worth $10025.0 as of 2024-06-30.

With 225.0 shares estimated at $875.0 under it, the former controlled 0.01% of total outstanding shares.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.